Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market
Holding LTRN?
Track your performance easily

Lantern Pharma (LTRN) Stock Forecast & Price Target

236 Followers
See the Price Targets and Ratings of:

LTRN Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Lantern
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LTRN Stock 12 Month Forecast

There Are No Analyst Ratings for LTRN In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

LTRN Financial Forecast

LTRN Earnings Forecast

Next quarter’s earnings estimate for LTRN is -$0.56 with a range of -$0.56 to -$0.56. The previous quarter’s EPS was -$0.46. LTRN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year LTRN has Outperformed its overall industry.
Next quarter’s earnings estimate for LTRN is -$0.56 with a range of -$0.56 to -$0.56. The previous quarter’s EPS was -$0.46. LTRN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year LTRN has Outperformed its overall industry.
No data currently available

LTRN Sales Forecast

Next quarter’s sales forecast for LTRN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. LTRN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year LTRN has Underperformed its overall industry.
Next quarter’s sales forecast for LTRN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. LTRN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year LTRN has Underperformed its overall industry.

LTRN Analyst Recommendation Trends

Rating
Aug 23
Nov 23
Mar 24
Apr 24
May 24
Strong Buy
2
1
0
0
0
Buy
0
0
0
0
0
Hold
2
2
3
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
3
3
4
In the current month, LTRN has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. LTRN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

LTRN Stock Forecast FAQ

What is LTRN’s average 12-month price target, according to analysts?
Currently, no data Available
What is LTRN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for LTRN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is LTRN a Buy, Sell or Hold?
      Currently, no data Available
      What is Lantern Pharma, Inc.’s price target?
      Currently, no data Available
      What do analysts say about Lantern Pharma, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of LTRN?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis